Skip to main content
Structure corrector neutralizes protein linked to Alzheimer's disease

Researchers at Gladstone Institutes reported in the journal Nature Medicine that they were able to neutralize the gene for apolipoprotein E4, associated with a high risk for Alzheimer's disease, and restored normal function to the brain cells. The researchers will now work with the pharmaceutical industry on clinical trials of the structure-correcting compound.

Full Story: